Asceneuron SA, a Switzerland-based company working on new compounds for neurodegenerative diseases, has appointed Christian Haass to its scientific advisory board. Professor Haass heads the Department of Metabolic Biochemistry at the Adolf-Butenandt Institute at Ludwig-Maximilians University and has been coordinating the German Center for Neurodegenerative Disorders since 2009.
Joining Prof Haass on the science board are Adam Boxer, professor at the University of California, San Francisco and Günter Höglinger, professor at the Technical University of Munich.
Asceneuron announced the appointments on 17 February 2015.